Open AccessPancreatic cancer treatment after FOLFIRINOX: prognostic importance of chemotherapy dose intensity and albumin/globulin ratio in second line
Author(s) -
Özgen Ahmet Yıldırım,
Erkan Erdur
Publication year - 2022
Publication title -
journal of health sciences and medicine :
Language(s) - English
Resource type - Journals
ISSN - 2636-8579
DOI - 10.32322/jhsm.1011658
Subject(s) - folfirinox , medicine , gemcitabine , neutropenia , chemotherapy , pancreatic cancer , clinical endpoint , gastroenterology , progression free survival , cancer , surgery , oncology , oxaliplatin , randomized controlled trial , colorectal cancer